Christopher Van Besien

Title: Christopher Van Besien: Innovator in Biological Activity Measurement

Introduction

Christopher Van Besien is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biological research, particularly in the measurement of receptor activity. His innovative approach has led to advancements in understanding the biological activity of urotensin II receptors.

Latest Patents

Christopher holds a patent for a method of measuring the biological activity of an urotensin II receptor. The patent describes how the administration of U-II to rats resulted in an increase in the redness or skin temperature of the rats' ears. This increase was inhibited by compounds that decrease the biological activity of the U-II/UT receptor. The invention provides methods for measuring the biological activity of an U-II receptor by monitoring the redness or skin temperature of an animal's ear. It also outlines the use of these methods to test compounds for their abilities to increase or decrease the biological activity of the U-II receptor. Christopher has 1 patent to his name.

Career Highlights

Christopher is currently employed at Janssen Pharmaceutica NV, where he continues to contribute to innovative research in the pharmaceutical industry. His work focuses on developing methods that enhance the understanding of biological processes and receptor interactions.

Collaborations

Throughout his career, Christopher has collaborated with notable colleagues, including Patricia Andrade-Gordon and Bruce P. Damiano. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Christopher Van Besien is a notable inventor whose work in measuring biological activity has the potential to impact various fields of research. His contributions to the understanding of urotensin II receptors exemplify the importance of innovation in scientific advancement.